Comparable stake leader
PRUDENTIAL FINANCIAL INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001404644.
Comparable stake leader
PRUDENTIAL FINANCIAL INC
Disclosed value leader
PRUDENTIAL FINANCIAL INC
Comparable rows
14/50
Latest evidence
30 Sep 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
14 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRUDENTIAL FINANCIAL INC |
13D/G
|
11%
Reported 13D/G
· 30 Sep 2026
|
$62,076,352
2,231,357 shares
|
$0 | 30 Sep 2026 |
| JENNISON ASSOCIATES LLC |
13D/G
|
11%
Reported 13D/G
· 30 Sep 2026
|
$62,013,061
2,229,082 shares
|
$0 | 30 Sep 2026 |
| Redmile Group, LLC |
13D/G
13F
Company
|
9.9%
Reported 13D/G
· 30 Jun 2026
|
$60,121,004
1,572,202 shares
|
+$574,480 | 30 Jun 2026 |
| EcoR1 Capital, LLC |
13F
13D/G
Company
|
9.9%
Reported 13D/G
· 30 Sep 2025
|
$35,368,734
1,271,342 shares
|
— | 30 Sep 2026 |
| Samsara BioCapital, L.P. |
13D/G
Srinivas Akkaraju
|
9.7%
Reported 13D/G
· 30 Sep 2026
|
$56,319,958
1,954,197 shares
|
$0 | 30 Sep 2026 |
| RTW INVESTMENTS, LP |
13F
13D/G
Company
|
9.3%
Reported 13D/G
· 30 Sep 2026
|
$42,076,526
1,512,456 shares
|
— | 30 Sep 2026 |
| Casdin Capital, LLC |
13F
13D/G
Company
|
8.7%
Reported 13D/G
· 31 Dec 2024
|
$44,104,743
1,585,361 shares
|
— | 30 Sep 2026 |
| BlackRock, Inc. |
13D/G
|
6.8%
Reported 13D/G
· 31 Mar 2025
|
$15,586,229
1,011,436 shares
|
$0 | 31 Mar 2025 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to selling over the last 12 months. Net value: -$1,133,592.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 9,600 | $0 | $339,962 | -$339,962 |
| 6-9 | 0 | 31,980 | $0 | $793,630 | -$793,630 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Showing 1-20 of 25 reporting-owner rows connected to Neurogene Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Rachel McMinn | NGNE | Common Stock | Options Exercise | 0.06% | 756 | 1,345,063 | 22 Sep 2026 | Direct | ||
| Rachel McMinn | NGNE | Stock Option (Right to Buy) | Options Exercise | -100% | -756 | 0 | 22 Sep 2026 | Direct | ||
| Christine Mikail Cvijic | NGNE | Common Stock | Sale | -4.76% | -$151,763 | $36.13 | -4,200 | 84,040 | 07 Jul 2026 | Direct |
| Christine Mikail Cvijic | NGNE | Common Stock | Sale | -0.68% | -$21,613 | $36.02 | -600 | 88,240 | 06 Jul 2026 | Direct |
| Christine Mikail Cvijic | NGNE | Common Stock | Sale | -4.37% | -$141,417 | $34.82 | -4,061 | 88,840 | 02 Jul 2026 | Direct |
| Christine Mikail Cvijic | NGNE | Common Stock | Sale | -0.79% | -$25,170 | $34.06 | -739 | 92,901 | 01 Jul 2026 | Direct |
| Christine Mikail Cvijic | NGNE | Common Stock | Sale | -9.3% | -$300,043 | $31.25 | -9,600 | 93,640 | 06 May 2026 | Direct |
| Christina Shafer | NGNE | Non-Qualified Stock Option (right to buy) | Award | 120,000 | 120,000 | 05 May 2026 | Direct | |||
| Christine Mikail Cvijic | NGNE | Common Stock | Sale | -2.42% | -$55,316 | $21.62 | -2,558 | 103,240 | 26 Mar 2026 | Direct |
| Rachel McMinn | NGNE | Common Stock | Sale | -0.25% | -$73,995 | $22.07 | -3,352 | 1,344,307 | 26 Mar 2026 | Direct |
| Julie Jordan | NGNE | Common Stock | Sale | -6.23% | -$18,128 | $21.89 | -828 | 12,472 | 26 Mar 2026 | Direct |
| Stuart Cobb | NGNE | Common Stock | Sale | -18.2% | -$141,446 | $20.81 | -6,797 | 30,497 | 13 Mar 2026 | Direct |
| Christine Mikail Cvijic | NGNE | Common Stock | Sale | -3.68% | -$84,176 | $20.81 | -4,045 | 105,798 | 13 Mar 2026 | Direct |
| Christine Mikail Cvijic | NGNE | Common Stock | Sale | -4.19% | -$120,526 | $25.11 | -4,800 | 109,843 | 27 Feb 2026 | Direct |
| Stuart Cobb | NGNE | Common Stock | Award | 79.4% | 16,500 | 37,294 | 20 Feb 2026 | Direct | ||
| Julie Jordan | NGNE | Common Stock | Award | 58.3% | 4,900 | 13,300 | 20 Feb 2026 | Direct | ||
| Julie Jordan | NGNE | Stock Option (Right to Buy) | Award | 29,600 | 29,600 | 20 Feb 2026 | Direct | |||
| Christine Mikail Cvijic | NGNE | Common Stock | Award | 23.8% | 22,000 | 114,643 | 20 Feb 2026 | Direct | ||
| Christine Mikail Cvijic | NGNE | Stock Option (Right to Buy) | Award | 131,900 | 131,900 | 20 Feb 2026 | Direct | |||
| Rachel McMinn | NGNE | Common Stock | Award | 1.96% | 25,900 | 1,347,659 | 20 Feb 2026 | Direct | ||
| Rachel McMinn | NGNE | Stock Option (Right to Buy) | Award | 155,100 | 155,100 | 20 Feb 2026 | Direct | |||
| Rohan Palekar | NGNE | Non-Qualified Stock Option (right to buy) | Award | 12,050 | 12,050 | 20 Feb 2026 | Direct | |||
| Robert Baffi | NGNE | Non-Qualified Stock Option (right to buy) | Award | 12,050 | 12,050 | 20 Feb 2026 | Direct | |||
| Sarah B. Noonberg | NGNE | Non-Qualified Stock Option (right to buy) | Award | 12,050 | 12,050 | 20 Feb 2026 | Direct | |||
| Cory S. Freedland | NGNE | Non-Qualified Stock Option (right to buy) | Award | 12,050 | 12,050 | 20 Feb 2026 | Direct | |||
| Keith Woods | NGNE | Non-Qualified Stock Option (right to buy) | Award | 12,050 | 12,050 | 20 Feb 2026 | Direct |